Delsys Pharmaceutical Overview

  • Founded
  • 1995
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $4M
Latest Deal Amount

Delsys Pharmaceutical General Information

Description

Developer of the Accudep process for formulating and manufacturing pharmaceutical preparations based on electrostatic deposition technology.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 11 Deerpark Drive
  • Suite 202
  • South Brunswick Township, NJ 08852
  • United States
+1 (732) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Delsys Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Aug-2000 $4M 000.00 000 Completed Generating Revenue
6. Later Stage VC (Series F) 25-Apr-2000 0000 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series E) 01-Apr-1999 000 000.00 000.00 Completed Product Development
4. Later Stage VC (Series D1) 28-Sep-1998 000 000.00 000.00 Completed Product Development
3. Later Stage VC (Series C) 14-Sep-1998 000.00 000.00 000.00 Completed Product Development
2. Early Stage VC (Series B) 06-Jul-1998 $7.67M $11.3M 000.00 Completed Startup
1. Early Stage VC (Series A) $3.68M $3.68M 00.000 Completed
To view Delsys Pharmaceutical’s complete valuation and funding history, request access »

Delsys Pharmaceutical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F 00,000,000 00.000000 000 00 00 00 00 00.000
Series E 0,000,000 00.000000 000 00 00 00 00 0.000
Series D2 0,000,000 00.000000
Series D1 0,000,000 00.000000 00 00 00 00 0.000
Series C 0,000,000 00.000000 000 00.0 00.0 00 00.0 00.000
Series B 9,590,000 $0.001000 10% $0.8 $0.8 1x $0.8 20.38%
Series A 4,197,458 $0.001000 10% $0.8 $0.8 1x $0.8 8.92%
To view Delsys Pharmaceutical’s complete cap table history, request access »

Delsys Pharmaceutical Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CenterPoint Ventures Venture Capital Minority 000 0000 000000 0
HealthCare Ventures Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Prism Venture Management Venture Capital Minority 000 0000 000000 0
Rho Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »